Compare BridgeBio Pharma Inc (BBIO) vs Deere & Company (DE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Deere & Company — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Deere & Company trades at $584.4 (market cap $158.09B). The key difference: Deere & Company is far larger — about 9.7× BridgeBio Pharma Inc's market cap, and Deere & Company pays a 1.11% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | DE | |
|---|---|---|
Market Cap | $16.27B | $158.09B |
Sector | Health | Industrials |
52-Week High | $90.17 | $662.49 |
52-Week Low | $44.81 | $439.11 |
Enterprise Value | $17.82B | $212.91B |
Dividend Yield | — | 1.11% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Read more on DE →
